Importantly, GLP-1 RAs cause weight loss, reduce hypoglycaemia (compared with sulfonylureas and insulin), and are one of the most effective glucose-lowering medications, which are effects that we have not incorporated [7]
Many research has shown promising results about the improvement of health status and intellectual development of individuals with DS, but the safety of doses and their efficiency have not been proved by independent scientific studies, especially in relation to the diet and nutrient status of DS individuals prior to supplementation
In a randomized, double-blind, placebo-controlled trial, tesamorelin reduced liver fat and was associated with less fibrosis progression, and a targeted proteomic and transcriptomic analysis of that trial showed the drug lowered fibro-inflammatory mediators including VEGFA, TGF-1, and CSF1
Relatively, TMA and TMAO are most likely to accumulate in the lungs and kidneys, followed by the liver, then muscles, with the heart being the least likely organ for accumulation (Smith et al., 1994)